Stealth Biotherapeutics

Developer of peptide therapy to treat rare mitochondrial diseases and its dysfunction-related disorders

placeNewton, Massachusetts, United States calendar_todayFounded 2007 groups31 employees language stealthbt.com

Registered entities

Innovation

95 patent families (39 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 7,707 times.

YearFilings
201512
201625
201721
201828
201935
202031
202131
202228
202330
202440
202535
202614

Social engagement

Social engagement: 15.2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Nan Fung Life Sciences.

Investor typeCountShare
Venture capital440%
Private equity110%
Bank & private debt220%
Other / undisclosed330%

Recent activity

12 Jun 2026
Recognition
9 Jun 2026
Event
World Orphan Drug Congress
27 May 2026
Event
Royal-Udall Foundation for the FDA meeting on Affecting the Aging Trajectory
Coming soon